Skip to content
Lower risk Drug recall · FDA · Published August 14, 2023

Baxter Bendamustine HCl Injection Recall: Missing Labels Risk Peeling

Baxter recalls Bendamustine HCl injection vials with missing or peeled labels. This could lead to incorrect dosing if the label is damaged. Affected vials have specific lot numbers and expiration dates.

🇺🇸 FDA recall #D-1103-2023DrugBaxter ›
Take action

Contact the company

Recalling firmBaxter Healthcare Corporation1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer

Baxter is recalling Bendamustine HCl injection vials that have missing or peeled labels. This could cause incorrect dosing if the label is damaged, which is serious for patients using the medication. Read more at govinfonow.com/recall/33209-baxter-bendamustine-hcl-injection-recall-missing-labels-risk-peeling.

Source Summary by GovInfoNow · govinfonow.com/recall/33209-baxter-bendamustine-hcl-injection-recall-missing-labels-risk-peeling · Updated August 17, 2026 · FDA enforcement record: FDA #D-1103-2023

Cite this page

“Baxter Bendamustine HCl Injection Recall: Missing Labels Risk Peeling.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33209-baxter-bendamustine-hcl-injection-recall-missing-labels-risk-peeling. Based on FDA recall #D-1103-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1103-2023%22&limit=1).

The FDA announced on August 14, 2023, that Baxter Healthcare Corporation is recalling Bendamustine HCl Injection due to missing or peeled labels. The recall affects 13,502 vials distributed nationwide.

How to tell if you have it

  • Brand: Baxter
  • Product: Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial
  • NDC: 10019-079-01
  • Lots: 3A004A (Exp 12/31/2024), 3A004B, 3B005A (Exp 1/31/2025)

The hazard

The hazard is missing labeling because customer complaints indicated that labels were partially or completely peeled off the injection vials.

Context

GovInfoNow's records show Baxter Healthcare Corporation has 187 other recalls on record since September 2, 2015. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026) and Asclemed Lidocaine HCl Injection Recall (June 8, 2026).

How to tell if you have this one

Check for vials with lot numbers 3A004A, 3A004B (expiring 12/31/2024) or 3B005A (expiring 1/31/2025). The product is a 4mL multiple-dose vial for prescription use.

  • Brand
    Baxter
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Label Condition

    Inspect the vial for missing or peeled labels. If labels are damaged, stop using the vial.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.A.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 16 days after the firm started it.

1. Firm started the recall: Aug 14, 202312. FDA classified it Class III: Aug 24, 202323. Published in FDA’s Enforcement Report: Aug 30, 202332023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product is safe if the label is intact. If the label is missing or peeled, it should not be used.

Similar recalls

Other Baxter recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1103-2023 (August 14, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1103-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA